MN 553 Advanced Pharmacology Final Exam
Question 1 4 / 4 points
Jim is being treated for hypertension. Because he has a history of heart att... [Show More] ack, the drug chosen is atenolol. Beta blockers treat hypertension by:
Increasing heart rate to improve cardiac output
Reducing vascular smooth muscle tone
Increasing aldosterone-mediated volume activity
Reducing aqueous humor production
Question 2 4 / 4 points
Opiates are used mainly to treat moderate to severe pain. Which of the following is NOT true about these drugs?
All opiates are scheduled drugs which require a DEA license to prescribe.
Opiates stimulate only mu receptors for the control of pain.
Most of the adverse effects of opiates are related to mu receptor stimulation.
Naloxone is an antagonist to opiates.
Question 3 4 / 4 points
When considering which cholesterol-lowering drug to prescribe, which factor determines the type and intensity of treatment?
Coronary artery disease risk level
Fasting total cholesterol
Question 4 4 / 4 points
Being competent in the use of information technology in clinical practice is expected in professional nurses. Advanced practice competence includes the ability to:
Search for information using the most common search engines
Serve as content experts in developing, implementing, and evaluating information Systems
Write programs to assure the integrity of health information
Use information technology to prescribe drugs
Question 5 4 / 4 points
The New York Heart Association and the Canadian Cardiovascular Society have described grading criteria for levels of angina. Angina that occurs with unusually strenuous activity or on walking or climbing stair after meals is class:
Question 6 4 / 4 points
An Investigational New Drug is filed with the U.S. Food and Drug Administration:
When the manufacturer has completed phase III trials
When a new drug is discovered
Prior to animal testing of any new drug entity
Prior to human testing of any new drug entity
Question 7 4 / 4 points
True contraindications to diphtheria, tetanus, and acellular pertussis (DTaP or Tdap) vaccine include:
Fever up to 104oF (40.5oC) after previous DTaP vaccine
Family history of seizures after DTaP vaccine
Anaphylactic reaction with a previous dose [Show Less]